COVID-19 therapeutic options for patients with kidney disease.

Izzedine, Hassan; Jhaveri, Kenar D; Perazella, Mark A

Izzedine, Hassan; Jhaveri, Kenar D; Perazella, Mark A.

Izzedine H; Department of Nephrology, Peupliers Private Hospital, Ramsay Générale de Santé, Paris, France. Electronic address: h.izzedine@ramsaygds.fr.
Jhaveri KD; Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA.
Perazella MA; Yale University School of Medicine, New Haven, Connecticut, USA.

Kidney Int ; 97(6): 1297-1298, 2020 06.

Article in English | MEDLINE | ID: covidwho-111076

Subject(s)

Antiviral Agents/administration & dosage; Betacoronavirus/isolation & purification; Coronavirus Infections/drug therapy; Off-Label Use; Pneumonia, Viral/drug therapy; Renal Insufficiency, Chronic/physiopathology; Antiviral Agents/adverse effects; Antiviral Agents/pharmacokinetics; Betacoronavirus/drug effects; COVID-19; Coronavirus Infections/virology; Dose-Response Relationship, Drug; Drug Dosage Calculations; Glomerular Filtration Rate/physiology; Humans; Kidney/drug effects; Kidney/physiopathology; Pandemics; Pneumonia, Viral/virology; Renal Elimination; Renal Insufficiency, Chronic/complications; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Renal Insufficiency, Chronic / Off-Label Use / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google